DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $147,537 | +2.2% | 604,495 | +0.5% | 0.38% | -45.0% |
| Q2 2023 | $144,299 | -13.4% | 601,244 | -9.0% | 0.69% | -20.1% |
| Q1 2023 | $166,574 | -8.2% | 660,903 | -3.4% | 0.86% | -13.0% |
| Q4 2022 | $181,530 | -99.9% | 683,936 | +0.2% | 0.99% | -2.7% |
| Q3 2022 | $176,313,000 | +2.7% | 682,617 | +0.8% | 1.02% | +7.9% |
| Q2 2022 | $171,728,000 | -25.3% | 677,375 | -13.6% | 0.94% | -9.7% |
| Q1 2022 | $230,005,000 | -12.2% | 784,117 | -1.6% | 1.04% | -2.6% |
| Q4 2021 | $262,046,000 | +5.8% | 796,468 | -2.1% | 1.07% | -1.7% |
| Q3 2021 | $247,593,000 | +13.4% | 813,274 | -0.0% | 1.09% | +14.9% |
| Q2 2021 | $218,294,000 | +16.1% | 813,436 | -2.6% | 0.95% | +8.1% |
| Q1 2021 | $187,982,000 | +1.2% | 835,179 | -0.1% | 0.88% | -2.4% |
| Q4 2020 | $185,678,000 | +2.0% | 835,859 | -1.1% | 0.90% | -6.6% |
| Q3 2020 | $182,013,000 | +17.7% | 845,276 | -3.3% | 0.96% | +9.0% |
| Q2 2020 | $154,587,000 | +27.5% | 874,215 | -0.2% | 0.88% | +4.6% |
| Q1 2020 | $121,237,000 | -9.0% | 875,930 | +0.9% | 0.84% | +12.5% |
| Q4 2019 | $133,277,000 | +5.8% | 868,368 | -0.5% | 0.75% | -2.1% |
| Q3 2019 | $125,997,000 | +4.9% | 872,371 | +3.8% | 0.77% | +4.1% |
| Q2 2019 | $120,135,000 | +9.4% | 840,578 | +1.1% | 0.74% | +5.1% |
| Q1 2019 | $109,787,000 | +28.9% | 831,592 | +0.7% | 0.70% | +14.5% |
| Q4 2018 | $85,146,000 | -5.1% | 825,695 | -0.0% | 0.61% | +12.9% |
| Q3 2018 | $89,748,000 | +45.5% | 825,956 | +32.1% | 0.54% | +35.5% |
| Q2 2018 | $61,702,000 | +0.7% | 625,272 | -0.0% | 0.40% | -1.7% |
| Q1 2018 | $61,251,000 | +9.8% | 625,580 | +4.1% | 0.41% | +14.6% |
| Q4 2017 | $55,766,000 | +22.3% | 600,792 | +13.0% | 0.36% | +7.9% |
| Q3 2017 | $45,589,000 | -15.8% | 531,470 | -17.1% | 0.33% | -17.3% |
| Q2 2017 | $54,116,000 | -4.7% | 641,259 | -3.4% | 0.40% | -7.7% |
| Q1 2017 | $56,774,000 | +9.0% | 663,786 | -0.8% | 0.43% | +3.6% |
| Q4 2016 | $52,068,000 | -1.2% | 668,905 | -0.5% | 0.42% | -2.6% |
| Q3 2016 | $52,681,000 | +15.7% | 672,039 | +49.0% | 0.43% | +13.3% |
| Q2 2016 | $45,548,000 | +5.1% | 450,974 | -1.2% | 0.38% | +5.6% |
| Q1 2016 | $43,320,000 | +2.7% | 456,670 | +0.6% | 0.36% | +0.6% |
| Q4 2015 | $42,182,000 | -42.3% | 454,156 | -47.1% | 0.36% | -45.0% |
| Q3 2015 | $73,119,000 | +3.6% | 858,098 | +4.0% | 0.64% | +11.6% |
| Q2 2015 | $70,601,000 | +0.3% | 824,878 | -0.5% | 0.58% | -0.3% |
| Q1 2015 | $70,405,000 | -1.3% | 829,268 | -0.4% | 0.58% | -1.7% |
| Q4 2014 | $71,362,000 | +7.0% | 832,597 | -5.1% | 0.59% | +3.1% |
| Q3 2014 | $66,684,000 | -3.9% | 877,657 | -0.5% | 0.57% | -2.4% |
| Q2 2014 | $69,414,000 | +8.2% | 881,666 | +3.1% | 0.59% | +6.9% |
| Q1 2014 | $64,164,000 | -3.1% | 855,519 | -0.3% | 0.55% | -3.7% |
| Q4 2013 | $66,238,000 | +9.5% | 858,000 | -1.7% | 0.57% | +2.0% |
| Q3 2013 | $60,497,000 | +9.0% | 872,720 | -0.5% | 0.56% | +6.7% |
| Q2 2013 | $55,516,000 | – | 877,032 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |